Amphetamine Sulfate

DRUG2 trials

Sponsors

Emory University, Arbor Pharmaceuticals, Inc.

Conditions

Attention Deficit Hyperactivity DisorderStroke

Phase 3

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

CompletedNCT03659929

Arbor Pharmaceuticals, Inc.Attention Deficit Hyperactivity Disorder

Start: 2018-09-18End: 2019-04-12Updated: 2024-09-03

Unknown Phase

Neurobiological Principles Applied to the Rehabilitation of Stroke Patients

CompletedNCT00715520

Emory UniversityStroke

Start: 2007-04-30End: 2016-09-30Updated: 2017-10-16

Related Papers

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry2021-08-233 citations